中国生物制药子公司北京泰德制药的新药TDI01拟纳入突破性治疗品种,用于治疗中重度慢性移植物抗宿主病。
Source Link中国生物制药子公司北京泰德制药的新药TDI01拟纳入突破性治疗品种,用于治疗中重度慢性移植物抗宿主病。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.